72,779 Shares in Certara, Inc. (NASDAQ:CERT) Purchased by Landscape Capital Management L.L.C.

Landscape Capital Management L.L.C. purchased a new stake in shares of Certara, Inc. (NASDAQ:CERT - Free Report) in the third quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 72,779 shares of the company's stock, valued at approximately $852,000.

A number of other large investors also recently bought and sold shares of the business. Sei Investments Co. increased its stake in Certara by 39.5% during the 2nd quarter. Sei Investments Co. now owns 997,871 shares of the company's stock valued at $13,821,000 after purchasing an additional 282,357 shares in the last quarter. Silvercrest Asset Management Group LLC increased its stake in Certara by 27.3% during the 1st quarter. Silvercrest Asset Management Group LLC now owns 516,300 shares of the company's stock valued at $9,231,000 after purchasing an additional 110,636 shares in the last quarter. Daventry Group LP increased its stake in Certara by 153.0% during the 2nd quarter. Daventry Group LP now owns 1,308,572 shares of the company's stock valued at $18,124,000 after purchasing an additional 791,405 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC increased its stake in Certara by 8.4% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 810,206 shares of the company's stock valued at $11,221,000 after purchasing an additional 62,912 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA increased its stake in Certara by 9.8% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 2,773,892 shares of the company's stock valued at $38,418,000 after purchasing an additional 248,448 shares in the last quarter. 73.96% of the stock is owned by hedge funds and other institutional investors.

Certara Price Performance

Shares of CERT stock traded up $0.59 during mid-day trading on Friday, hitting $10.36. The company had a trading volume of 1,595,745 shares, compared to its average volume of 1,092,893. Certara, Inc. has a 52-week low of $9.41 and a 52-week high of $19.87. The stock's 50 day moving average price is $10.79 and its 200-day moving average price is $13.22. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.86 and a quick ratio of 2.86. The company has a market capitalization of $1.67 billion, a P/E ratio of -51.80, a P/E/G ratio of 4.94 and a beta of 1.51.

Certara (NASDAQ:CERT - Get Free Report) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.13 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.11 by $0.02. The company had revenue of $94.80 million for the quarter, compared to the consensus estimate of $95.51 million. Certara had a negative net margin of 8.34% and a positive return on equity of 3.43%. Certara's revenue was up 10.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.06 earnings per share. Equities research analysts forecast that Certara, Inc. will post 0.28 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the stock. UBS Group upgraded shares of Certara from a "neutral" rating to a "buy" rating and set a $16.00 price target for the company in a research note on Friday, September 27th. Robert W. Baird reduced their price target on shares of Certara from $18.00 to $13.00 and set a "neutral" rating for the company in a research note on Tuesday, November 5th. Finally, Barclays reduced their price target on shares of Certara from $14.00 to $12.00 and set an "equal weight" rating for the company in a research note on Thursday, November 7th. Six equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, Certara currently has an average rating of "Hold" and a consensus target price of $15.92.

Insider Activity at Certara

In other Certara news, insider Leif E. Pedersen sold 51,224 shares of the business's stock in a transaction on Monday, September 9th. The shares were sold at an average price of $11.29, for a total transaction of $578,318.96. Following the transaction, the insider now owns 99,704 shares in the company, valued at $1,125,658.16. The trade was a 33.94 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Patrick F. Smith sold 5,409 shares of the company's stock in a transaction dated Monday, October 7th. The stock was sold at an average price of $11.03, for a total transaction of $59,661.27. Following the completion of the transaction, the insider now owns 50,091 shares in the company, valued at approximately $552,503.73. The trade was a 9.75 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.39% of the stock is owned by insiders.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.